Company profile for Amniotics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient.Amniotic's platform enables the extraction of Mesenchymal Stem Cells (MSC) from amniotic fluid, which is recovered from healthy voluntary donors in connection with planned caesarean sections.Amniotics has a project portfolio where the same technology and methodology can be...
We are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient.Amniotic's platform enables the extraction of Mesenchymal Stem Cells (MSC) from amniotic fluid, which is recovered from healthy voluntary donors in connection with planned caesarean sections.Amniotics has a project portfolio where the same technology and methodology can be applied for various indications.Our procedure for collecting term amniotic fluid from voluntary healthy donors is performed at full-term planned caesarean deliveries.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Medicon Village, Scheelevägen 2, 223 63 Lund
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.marketscreener.com/quote/stock/AMNIOTICS-AB-PUBL-124498346/news/Amniotics-led-consortium-selected-for-EIC-Pathfinder-grant-of-3-8-million-from-the-European-Innovat-42302929/

NEWSWISE
14 Nov 2022

https://storage.mfn.se/ed7b5268-ea68-4eac-9178-6958f6a6a214/amniotics-announces-first-patient-dosed-in-phase-ib-study-with-pulmostem-to-treat-severe-viral-lung-disease.pdf

STORAGE
11 Oct 2022

https://storage.mfn.se/370ea1e0-53c2-4d38-b122-3697bc04c9f6/amniotics-granted-key-u-s-patent-for-pulmostem.pdf

STORAGE
10 Aug 2022

https://www.bloomberg.com/news/articles/2022-08-10/pfizer-pfe-biontech-bntx-aim-to-preserve-immunity-with-pan-coronavirus-shot

Madison Muller BLOOMBERG
10 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty